Jensen, Patrizia
Carlet, Michela
Schlenk, Richard F. http://orcid.org/0000-0003-2215-2059
Weber, Andrea
Kress, Jana
Brunner, Ines
Słabicki, Mikołaj
Grill, Gregor
Weisemann, Simon
Cheng, Ya-Yun
Jeremias, Irmela http://orcid.org/0000-0003-1773-7677
Scholl, Claudia http://orcid.org/0000-0001-6768-322X
Fröhling, Stefan http://orcid.org/0000-0001-7907-4595
Funding for this research was provided by:
German José Carreras Leukemia Foundation (DJCLS), Grant number F 15/04
Stipend from the German Academic Scholarship Foundation
Stipend from the Helmholtz International Graduate School for Cancer Research
Article History
Received: 3 February 2020
Revised: 10 June 2020
Accepted: 17 June 2020
First Online: 26 June 2020
Compliance with ethical standards
:
: SF has had a consulting or advisory role, received honoraria, research funding, and/or travel/accommodation expenses funding from the following for-profit companies: Amgen, AstraZeneca, Bayer, Eli Lilly, Pfizer, PharmaMar, and Roche. RFS has had a consulting or advisory role, received honoraria, research funding, and/or travel/accommodation expenses funding from the following for-profit companies: Roche, Daiichi Sankyo, Pfizer, Novartis, PharmaMar, and AstraZeneca. The other authors declare no competing financial interests.